<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="covid_vaccine/PMC7431281/results/search/drugs/results.xml">
  <result pre="pandemic, possible repositioning of various antiviral and antiparasitic drugs including" exact="hydroxychloroquine" post="and chloroquine, remdesivir, protease inhibitors—lopinavir and ritonavir, etc. previously"/>
  <result pre="Isotretinoin in Treatment of COVID-19 Not yet recruiting COVID-19 Drug:" exact="isotretinoin" post="only product in oral dose form 28 Convalescent Plasma"/>
  <result pre="Study Not yet recruiting Coronavirus Coronavirus infection Drug: plasma Drug:" exact="hydroxychloroquine" post="• Universidad del Rosario, Bogota, Cundinamarca, Colombia 33 Methodist"/>
  <result pre="in Outpatients Infected with COVID-19 Not yet recruiting COVID-19 Drug:" exact="melatonin" post="Other: placebo (methylcellulose) capsule • University at Buffalo, Buffalo,"/>
  <result pre="COVID-19 Not yet recruiting Coronavirus infection Hydroxychloroquine adverse reaction Drug:" exact="hydroxychloroquine" post="sulfate 200 mg (mg) tab 52 Validation of COVID-19"/>
  <result pre="Nitric Oxide for Preventing Progression in COVID-19 Recruiting COVID-19 Drug:" exact="nitric oxide" post="• Tufts Medical Center, Boston, MA, USA 78 Cohort"/>
  <result pre="Risk Healthcare Workers During the COVID-19 Pandemic Suspended COVID-19 Drug:" exact="hydroxychloroquine" post="Drug: placebos • ISGlobal, Barcelona, Spain 82 Evaluating Clinical"/>
  <result pre="Tramadol in COVID-19 Egyptian Patients Not yet recruiting COVID-19 Drug:" exact="tramadol" post="Other: standard care delivered in the isolation hospitals Hydroxychloroquine"/>
  <result pre="Lung and Blood Institute, evaluating the safety and effectiveness of" exact="hydroxychloroquine" post="for treatment of adults hospitalized with COVID-19. The preliminary"/>
  <result pre="of adults hospitalized with COVID-19. The preliminary studies indicate that" exact="chloroquine" post="and hydroxychloroquine have the potential to improve disease outcomes"/>
  <result pre="hospitalized with COVID-19. The preliminary studies indicate that chloroquine and" exact="hydroxychloroquine" post="have the potential to improve disease outcomes and possibly"/>
  <result pre="vitro and clinical studies demonstrated that the antiviral action of" exact="hydroxychloroquine" post="might be effective in limiting SARS-CoV-2 infection [49, 50]."/>
  <result pre="in limiting SARS-CoV-2 infection [49, 50]. Further, a combination of" exact="hydroxychloroquine" post="and azithromycin has also been used against the pathophysiology"/>
  <result pre="SARS-CoV-2 infection [49, 50]. Further, a combination of hydroxychloroquine and" exact="azithromycin" post="has also been used against the pathophysiology of COVID-19"/>
  <result pre="COVID-19 [51] and is under clinical trial against SARS-CoV-2. The" exact="chloroquine" post="drug appears to interfere with terminal glycosylation of ACE2"/>
  <result pre="coronaviruses showing a strong impact on SARS-CoV infection [52–55]. Moreover," exact="chloroquine" post="and hydroxychloroquine are known to modulate the immune response"/>
  <result pre="a strong impact on SARS-CoV infection [52–55]. Moreover, chloroquine and" exact="hydroxychloroquine" post="are known to modulate the immune response in some"/>
  <result pre="effects of the SARS-CoV-2 infection. A preliminary clinical trial of" exact="chloroquine" post="repurposing against SARS-CoV-2 infection has shown some positive results,"/>
  <result pre="Institutes of Health (NIH), USA, stopped the clinical trial of" exact="hydroxychloroquine" post="as a potential therapy for COVID-19 because some studies"/>
  <result pre="now emerging. Recent systematic studies demonstrated no significant benefit of" exact="hydroxychloroquine" post="drug in COVID-19 treatment [57, 58]. Besides, the clinical"/>
  <result pre="in vivo activityInt J Parasitol Drugs Drug Resist20188345946430396013 35.WangMCaoRZhangLYangXLiuJXuMShiZHuZZhongWXiaoGRemdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019- nCoV)"/>
  <result pre="emerged novel coronavirus (2019- nCoV) in vitroCell Res202030326927132020029 36.YazdanyJKimAHJUse of" exact="hydroxychloroquine" post="and chloroquine during the COVID-19 pandemic: what every clinician"/>
  <result pre="coronavirus (2019- nCoV) in vitroCell Res202030326927132020029 36.YazdanyJKimAHJUse of hydroxychloroquine and" exact="chloroquine" post="during the COVID-19 pandemic: what every clinician should knowAnn"/>
  <result pre="JM, Lagier JC, Brouqui P, Raoult D (2020) Chloroquine and" exact="hydroxychloroquine" post="as available weapons to fight COVID-19. Int J Antimicrob"/>
  <result pre="weapons to fight COVID-19. Int J Antimicrob Agents:105932. 10.1016/j.ijantimicag.2020.105932 38.GuastalegnameMValloneACould" exact="chloroquine" post="/hydroxychloroquine be harmful in coronavirus disease 2019 (COVID-19) treatment?Clin"/>
  <result pre="coronavirus (2019-nCoV)Nat Rev Drug Discov202019314915032127666 44.RainsfordKParkeALClifford-RashotteMKeanWTherapy and pharmacological properties of" exact="hydroxychloroquine" post="and chloroquine in treatment of systemic lupus erythematosus, rheumatoid"/>
  <result pre="Rev Drug Discov202019314915032127666 44.RainsfordKParkeALClifford-RashotteMKeanWTherapy and pharmacological properties of hydroxychloroquine and" exact="chloroquine" post="in treatment of systemic lupus erythematosus, rheumatoid arthritis and"/>
  <result pre="vitro antiviral activity and projection of optimized dosing design of" exact="hydroxychloroquine" post="for the treatment of severe acute respiratory syndrome coronavirus"/>
  <result pre="B, Rolain JM, Brouqui P, Raoult D (2020) Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: results of an open-label"/>
  <result pre="inhibitor of SARS coronavirus infection and spreadVirol J200526916115318 53.RolainJMColsonPRaoultDRecycling of" exact="chloroquine" post="and its hydroxyl analogue to face bacterial, fungal and"/>
  <result pre="Raoult D (2020) New insights on the antiviral effects of" exact="chloroquine" post="against coronavirus: what to expect for COVID-19? Int J"/>
  <result pre="expect for COVID-19? Int J Antimicrob Agents:105938. 10.1016/j.ijantimicag.2020.105938 55.SavarinoABoelaertJRCassoneAMajoriGCaudaREffects of" exact="chloroquine" post="on viral infections: an old drug against today's diseases?Lancet"/>
  <result pre="YM, Pasupuleti V, Barboza JJ, White CM (2020) Hydroxychloroquine or" exact="chloroquine" post="for treatment or prophylaxis of COVID-19: a living systematic"/>
  <result pre="systematic review. Ann Intern Med. 10.7326/M20-2496 58.BoulwareDRPullenMFBangdiwalaASPastickKALofgrenSMOkaforECSkipperCPNasceneAANicolMRAbassiMEngenNWChengMPLaBarDLotherSAMacKenzieLJDrobotGMartenNZarychanskiRKellyLESchwartzISMcDonaldEGRajasinghamRLeeTCHullsiekKHA randomized trial of" exact="hydroxychloroquine" post="as postexposure prophylaxis for Covid-19N Engl J Med202038351752532492293 59.National"/>
  <result pre="blockade for cytokine stormImmunotherapy20168895997027381687 81.immunomodulatory therapy in COVID-19: role of" exact="chloroquine" post="and anti-IL-6 monoclonal antibodies. Int J Antimicrob Agents:105982 10.1016/j.ijantimicag.2020.105982"/>
 </snippets>
</snippetsTree>
